A nearly 3% pullback in Pfizer (NYSE: PFE) after the drug giant reported flat quarterly revenue pulled down exchange traded funds (ETFs) that track healthcare and pharmaceuticals stocks on Tuesday. “Excluding the impact of foreign exchange rates, total sales fell 1% year over year as patent losses...